Quick Summary
- Persistent numbness that doesn't resolve with position change may indicate neuropathy, not simple compression.
- Large-fibre neuropathy: numbness, loss of vibration sense, balance problems — detected by nerve conduction studies.
- Small-fibre neuropathy: burning pain, temperature sensitivity — often missed by standard nerve tests.
- If numbness persists beyond 2 weeks without clear positional cause, seek medical evaluation.
When Does Numbness Qualify as "Persistent"?
Clinically, numbness transitions from transient to clinically significant when it meets any of these chronicity criteria:
- Duration: Numbness that persists continuously for >2 weeks without a clear positional or mechanical cause
- Recurrence: Episodes recurring in the same distribution on most days for >4 weeks
- Progression: Numbness that is spreading to new areas (e.g., from toes to ankles, or from feet to hands)
- Associated deficits: Numbness accompanied by reduced vibration sense, absent reflexes, weakness, or gait imbalance
- Bilateral symmetry: Numbness affecting both feet (or both hands and feet) in a symmetric pattern — this almost always indicates a systemic process
Meeting any one of these criteria warrants medical evaluation. Meeting two or more — particularly progression + bilateral symmetry — warrants urgent neurological assessment
Large-Fibre vs. Small-Fibre Neuropathy: Why the Distinction Matters
Peripheral nerves contain multiple fibre types, and different diseases preferentially damage different fibres. Understanding which fibres are affected determines both the diagnostic approach and the clinical significance:
| Feature | Large-Fibre Neuropathy | Small-Fibre Neuropathy |
|---|---|---|
| Fibre types affected | Myelinated Aα (motor) and Aβ (touch, vibration, proprioception) | Unmyelinated C-fibres (pain, warmth) and thinly myelinated Aδ (sharp pain, cold) |
| Predominant symptoms | Numbness, imbalance, clumsiness, difficulty with fine motor tasks | Burning pain, allodynia (pain from light touch), electric shocks, autonomic dysfunction |
| Sensory examination | Reduced vibration (128Hz tuning fork), reduced proprioception, positive Romberg | Reduced pinprick and temperature sensation; vibration and proprioception preserved |
| Reflexes | Reduced or absent (ankle reflex first) | Typically preserved |
| Motor involvement | May include weakness and muscle wasting | No motor weakness |
| NCS/EMG findings | Abnormal — reduced SNAP/CMAP amplitudes or slowed conduction | Often normal — standard NCS cannot detect C-fibre or Aδ damage |
| Gold standard test | Nerve conduction studies (NCS/EMG) | Skin punch biopsy — intraepidermal nerve fibre density (IENFD) |
| Common causes | B12 deficiency, diabetes, GBS/CIDP, alcohol, chemotherapy | Diabetes (early), impaired glucose tolerance, Sjögren's, sarcoidosis, idiopathic (30–50%) |
Clinical pearl: A patient with persistent burning foot pain and normal NCS does not have "nothing wrong" — they likely have small-fibre neuropathy. Skin punch biopsy at the distal leg (10 cm above the lateral malleolus) measuring IENFD is the diagnostic confirmation. Values <2 standard deviations below age-matched normative data confirm the diagnosis
B12 Deficiency: The Most Important Reversible Cause of Persistent Numbness
Vitamin B12 deficiency deserves specific attention because it is common, often missed, and fully reversible when caught early — but causes permanent damage when delayed
The biochemical mechanism
B12 (cobalamin) is the essential cofactor for two enzymes:
- Methionine synthase: Converts homocysteine → methionine → S-adenosylmethionine (SAMe). SAMe is the universal methyl donor for myelin phospholipid synthesis. B12 deficiency → SAMe depletion → demyelination of dorsal columns (proprioception/vibration) and peripheral nerves
- Methylmalonyl-CoA mutase: Converts methylmalonyl-CoA → succinyl-CoA. B12 deficiency → methylmalonic acid (MMA) accumulates → incorporated into fatty acids → structurally abnormal myelin that degrades prematurely
Diagnostic thresholds and the grey zone
| Marker | Normal | Grey Zone | Deficient |
|---|---|---|---|
| Serum B12 | >400 pg/mL | 200–400 pg/mL | <200 pg/mL |
| Methylmalonic acid (MMA) | <0.4 μmol/L | 0.4–0.75 μmol/L | >0.75 μmol/L |
| Homocysteine | <10 μmol/L | 10–15 μmol/L | >15 μmol/L |
Critical point: Neurological damage from B12 deficiency can occur even when serum B12 is in the "grey zone" (200–400 pg/mL). In patients with persistent numbness and grey-zone B12, elevated MMA confirms functional deficiency and justifies treatment. Up to 30% of patients with neurological B12 deficiency have serum levels in the low-normal range (Hunt 2014)
Why early detection matters
B12-related neurological damage follows a reversibility window:
- Symptoms <6 months: Full or near-full recovery expected with adequate B12 repletion
- Symptoms 6–12 months: Partial recovery likely; some residual deficits may persist
- Symptoms >12 months: Significant permanent damage likely — demyelinated axons undergo secondary axonal degeneration that is irreversible
Other Common Causes of Persistent Numbness
Diabetic neuropathy
The most common cause of persistent numbness worldwide. Chronic hyperglycaemia damages nerves through polyol pathway activation (sorbitol accumulation), advanced glycation end-products (AGEs), protein kinase C activation, and oxidative stress. Diagnostic threshold: HbA1c ≥6.5%. Even pre-diabetes (impaired glucose tolerance) can cause small-fibre neuropathy — this is increasingly recognised as a cause of "idiopathic" burning feet
Chronic entrapment
Untreated carpal tunnel syndrome or cubital tunnel syndrome can progress from intermittent nocturnal tingling to persistent numbness with sensory loss and motor weakness. The transition occurs when chronic demyelination progresses to axonal loss — at this stage, recovery after decompression surgery is incomplete. This is why persistent numbness in a median or ulnar nerve distribution warrants timely NCS evaluation
Cervical/lumbar radiculopathy
Persistent numbness in a dermatome distribution (e.g., L5 = top of foot, C6 = thumb) with associated weakness and reflex changes suggests chronic nerve root compression from disc herniation or spinal stenosis. MRI of the relevant spine segment is the diagnostic standard
Medication-induced neuropathy
Long-term metformin use depletes B12 (de Jager 2010 — up to 30% of long-term users). Chemotherapy agents (cisplatin, oxaliplatin, taxanes) cause dose-dependent cumulative axonal damage. Isoniazid depletes active B6 (P5P). Recognition of the medication link is key because stopping the offending agent (or supplementing the depleted vitamin) can halt progression
Alcohol-related neuropathy
Combines direct alcohol neurotoxicity with thiamine (B1) deficiency from impaired absorption and utilisation. Presents as painful burning neuropathy in the feet. Thiamine supplementation (benfotiamine form has superior bioavailability via THTR-1/2 transporter bypass) plus alcohol cessation can improve symptoms
The Complete Diagnostic Workup for Persistent Numbness
A systematic approach based on clinical guidelines (England 2009, AAN practice parameter):
Step 1 — Clinical examination
- Sensory testing: Vibration (128Hz tuning fork at great toe), pinprick, temperature, light touch (monofilament), proprioception (joint position sense)
- Motor testing: Strength grading in distal muscles (toe extension, ankle dorsiflexion, finger abduction, grip strength)
- Reflexes: Ankle, knee, biceps, triceps — document absent, reduced, or normal
- Provocative tests: Tinel's, Phalen's (if entrapment suspected); Spurling's, straight leg raise (if radiculopathy suspected)
- Gait and balance: Romberg test, tandem gait
Step 2 — First-tier blood tests
- Serum B12 + methylmalonic acid (MMA) + homocysteine — the trio needed to detect both overt and functional B12 deficiency
- HbA1c + fasting glucose — diabetes and pre-diabetes screening
- TSH — hypothyroidism (increases entrapment risk, slows conduction)
- Complete blood count — macrocytic anaemia (B12/folate), anaemia of chronic disease
- Renal function (eGFR, creatinine) — uraemic neuropathy
- Liver function tests — hepatic neuropathy, alcohol-related damage
Step 3 — Electrodiagnostic studies (NCS/EMG)
Indicated when clinical examination suggests neuropathy, entrapment, or radiculopathy. NCS characterises the neuropathy:
- Axonal: Reduced SNAP/CMAP amplitudes with preserved conduction velocity — typical of B12, diabetes, alcohol, chemotherapy
- Demyelinating: Slowed conduction velocity, prolonged distal latencies, conduction block — typical of GBS, CIDP, hereditary neuropathies
- Mixed: Features of both — suggests severe or advanced disease
Step 4 — Advanced testing (when indicated)
- Skin punch biopsy: When small-fibre neuropathy is suspected (burning pain, normal NCS). Measures IENFD at distal leg
- Oral glucose tolerance test: When HbA1c is normal but impaired glucose tolerance is suspected as cause of small-fibre neuropathy
- Autoimmune panel: ANA, ESR, anti-ganglioside antibodies, serum protein electrophoresis — when inflammatory or paraproteinaemic neuropathy is considered
- MRI spine: When radiculopathy or myelopathy is suspected
- Lumbar puncture: Elevated CSF protein with normal cell count (albuminocytologic dissociation) supports GBS/CIDP
Red Flags: When Persistent Numbness Requires Urgent Evaluation
Emergency evaluation needed for:
- • Rapidly ascending numbness and weakness over hours to days (Guillain-Barré syndrome)
- • Bilateral leg numbness with bladder/bowel dysfunction (cauda equina syndrome — surgical emergency)
- • Sudden unilateral numbness with weakness or speech changes (stroke)
- • Saddle anaesthesia (perineal numbness) — cauda equina until proven otherwise
Non-emergency but urgent: Progressive motor weakness (especially foot drop or hand weakness), rapidly spreading sensory loss, or persistent numbness with thenar or intrinsic hand muscle wasting — these warrant neurological referral within days
Conclusion
Persistent numbness is fundamentally different from positional tingling. It indicates structural nerve damage — either demyelination (potentially reversible) or axonal loss (often permanent). The distinction between large-fibre and small-fibre neuropathy determines both the diagnostic pathway and the prognosis
The most important treatable cause — B12 deficiency — has a reversibility window that closes over months. Serum B12 alone can miss functional deficiency; MMA and homocysteine testing are essential when B12 is in the grey zone (200–400 pg/mL)
For a comprehensive ranked differential of all tingling causes, see Top 7 Causes of Tingling in Hands and Feet. For nocturnal patterns specifically, see Tingling During Sleep: Positional vs. Pathological